Accordingly and in a previous preclinical study, the imidazole-based H3R antagonists, namely thioperamide and ciproxifan, improved the decreased prepulse inhibition in an animal model of SCH (Brown et al., 2013; Figure 2, Table 4). This evidence concerns the gene HRH3 and spindle cell hemangioma.